AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,303,000 | +7.0% | 1,992,022 | +22.4% | 0.06% | +17.0% |
Q2 2023 | $46,076,000 | +38.6% | 1,626,960 | +12.4% | 0.05% | +35.9% |
Q1 2023 | $33,247,000 | -16.2% | 1,447,388 | +2.5% | 0.04% | -17.0% |
Q4 2022 | $39,660,000 | +1.9% | 1,412,409 | +2.6% | 0.05% | -2.1% |
Q3 2022 | $38,934,000 | +29.9% | 1,376,239 | +1.8% | 0.05% | +41.2% |
Q2 2022 | $29,976,000 | -29.7% | 1,352,111 | -7.7% | 0.03% | +6.2% |
Q1 2022 | $42,644,000 | +11.5% | 1,464,932 | +25.9% | 0.03% | 0.0% |
Q4 2021 | $38,260,000 | -28.2% | 1,163,984 | +0.7% | 0.03% | -28.9% |
Q3 2021 | $53,320,000 | -16.2% | 1,155,360 | +0.1% | 0.04% | -13.5% |
Q2 2021 | $63,637,000 | +8.5% | 1,154,724 | +1.6% | 0.05% | -37.3% |
Q1 2021 | $58,676,000 | +23.6% | 1,136,257 | +3.7% | 0.08% | +20.3% |
Q4 2020 | $47,487,000 | +9.9% | 1,095,947 | -11.2% | 0.07% | -5.5% |
Q3 2020 | $43,194,000 | -34.3% | 1,234,135 | +0.4% | 0.07% | -35.4% |
Q2 2020 | $65,746,000 | +64.0% | 1,229,350 | +8.8% | 0.11% | +37.8% |
Q1 2020 | $40,092,000 | -19.6% | 1,130,017 | +8.2% | 0.08% | +15.5% |
Q4 2019 | $49,857,000 | +82.3% | 1,044,127 | +23.7% | 0.07% | +54.3% |
Q3 2019 | $27,347,000 | +11062.0% | 844,030 | +22866.8% | 0.05% | – |
Q3 2017 | $245,000 | -63.8% | 3,675 | -77.9% | 0.00% | -100.0% |
Q1 2016 | $676,000 | -67.7% | 16,644 | -48.3% | 0.00% | -75.0% |
Q4 2015 | $2,092,000 | +6.2% | 32,218 | +15.5% | 0.00% | 0.0% |
Q3 2015 | $1,969,000 | -34.8% | 27,887 | +2.5% | 0.00% | -33.3% |
Q2 2015 | $3,022,000 | +45.0% | 27,195 | +23.1% | 0.01% | +50.0% |
Q1 2015 | $2,084,000 | +44.8% | 22,095 | +72.0% | 0.00% | +33.3% |
Q4 2014 | $1,439,000 | +1430.9% | 12,844 | +432.7% | 0.00% | – |
Q1 2014 | $94,000 | – | 2,411 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |